⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5191107 | 0.79 | — | — | |
| SCHEMBL43753 | 0.78 | — | — | |
| SCHEMBL23355931 | 0.78 | — | — | |
| SCHEMBL58479 | 0.78 | — | — | |
| SCHEMBL104576 | 0.75 | — | — | |
| SCHEMBL7779245 | 0.75 | TSHR (0.33) | — | |
| SCHEMBL59981 | 0.73 | — | — | |
| SCHEMBL11434209 | 0.72 | — | — | |
| SCHEMBL5987195 | 0.71 | TSHR (0.35) | — | |
| SCHEMBL232421 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023064493-A1 | COMPOUNDS AND METHODS FOR TREATING CORONAVIRUSES | Clear Creek Bio, Inc. (US) | 2023-04-20 | — | — | WO | disclosed |
| WO-2021189046-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF SARS-COV-2 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2021-09-23 | — | — | WO | disclosed |
| US-9617276-B2 | Compounds and methods for treating AIDS and HIV infections | PURDUE RESEARCH FOUNDATION (US) | 2017-04-11 | — | — | US | disclosed |
| US-20150111962-A1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-04-23 | — | — | US | disclosed |
| US-8921349-B2 | Compounds and methods for treating AIDS and HIV infections | PURDUE RESEARCH FOUNDATION (US) | 2014-12-30 | — | — | US | disclosed |
| US-8703947-B2 | Compounds for treatment of Alzheimer's disease | PURDUE RESEARCH FOUNDATION (US) | 2014-04-22 | — | — | US | disclosed |
| EP-2429290-B1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | PURDUE RESEARCH FOUNDATION (US) | 2014-01-01 | — | — | EP | disclosed |
| US-8394807-B2 | Quinazoline inhibitors of BACE 1 and methods of using | PURDUE RESEARCH FOUNDATION (US) | 2013-03-12 | — | — | US | disclosed |
| EP-2429290-A1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | Purdue Research Foundation (US) | 2012-03-21 | — | — | EP | disclosed |
| US-20120059161-A1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | PURDUE RESEARCH FOUNDATION (US) | 2012-03-08 | — | — | US | disclosed |
| US-20110269834-A1 | COMPOUNDS AND METHODS FOR TREATING RESPIRATORY DISEASES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2011-11-03 | — | — | US | disclosed |
| EP-2376083-A1 | QUINAZOLINE INHIBITORS OF BACE 1 AND METHODS OF USING | Purdue Research Foundation (US) | 2011-10-19 | — | — | EP | disclosed |
| US-20110230505-A1 | QUINAZOLINE INHIBITORS OF BACE 1 AND METHODS OF USING | PURDUE RESEARCH FOUNDATION (US) | 2011-09-22 | — | — | US | disclosed |
| US-20110195978-A1 | COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASE | PURDUE RESEARCH FOUNDATION (US) | 2011-08-11 | — | — | US | disclosed |
| EP-2349308-A1 | COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASE | Purdue Research Foundation (US) | 2011-08-03 | — | — | EP | disclosed |
| WO-2010132494-A1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | GHOSH ARUN K (US) | 2010-11-18 | — | — | WO | disclosed |
| WO-2010059953-A1 | QUINAZOLINE INHIBITORS OF BACE 1 AND METHODS OF USING | PURDUE RESEARCH FOUNDATION (US) | 2010-05-27 | — | — | WO | disclosed |
| WO-2010042796-A1 | COMPOUNDS FOR TREATMENT OF ALZHEIMER'S DISEASE | PURDUE RESEARCH FOUNDATION (US) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010022355-A1 | COMPOUNDS AND METHODS FOR TREATING RESPIRATORY DISEASES | PURDUE RESEARCH FOUNDATION (US) | 2010-02-25 | — | — | WO | disclosed |